logo

For the Inventor, By the Inventor

Flemington, NJ, United States of America

Barbara S Rauckman

This inventor holds 20 USPTO granted patents, plus 2 CIPO patents and 1 EPO patent, primarily in Pharmaceutical Chemistry. Top assignees: Hoechst Roussel Pharmaceuticals, Hoechst Marion Roussel, Aventis Pharmaceuticals Inc.. Active years: 1994-2012.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Barbara S Rauckman. Retrieved from https://idiyas.com/inventor/barbara-s-rauckman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 20

% Patents Active = 90.0



Average Co-Inventor Count = 4.8

ph-index = 4

Forward Citations = 93(Granted Patents)


Company Filing History:

goldMedal11 out of 539 
 
Hoechst Roussel Pharmaceuticals
 patents
silverMedal4 out of 236 
 
Hoechst Marion Roussel
 patents
bronzeMedal2 out of 207 
 
Aventis Pharmaceuticals Inc.
 patents
4. 1 out of 1 
 
Aventis Hoklings Inc.
 patent
5. 1 out of 1 
 
Hoescht Roussel Pharmaceuticals Inc.
 patent
6. 1 out of 1,547 
 
Sanofi
 patents

Years Active: 1994-2012

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
Pyrimidine
Hydrazide
PGDS Inhibitors
Amino Propanediols
Physostigmine
Carbamate Derivatives
Benzo[D]isothiazoles
Aryl Compounds
Substituted Piperidinyl
Chemical Synthesis
Pharmaceuticals
Drug Development
20 patents (USPTO):Explore Patents
1. 8258130 - Pyrimidine hydrazide compounds as PGDS inhibitors (2012-09-04),
2. 7511046 - [object Object] (2009-03-31),
3. 7125903 - [object Object] (2006-10-24),
4. 6500849 - 1-alkyl-, 1-alkenyl-, and 1-alkynylaryl-2-amino 1,3-propanediols and related compounds (2002-12-31),
5. 5977147 - 1-alkyl-, 1-alkenyl-, and 1-alkynylaryl-2-amino- 1,3-propanediols and (1999-11-02),
6. 5972963 - 3-aryl-2-(1-substituted 4-piperidinyl)-1,1-dioxo-3H-benzo[D]isothiazoles (1999-10-26),
7. 5677457 - Method of preparation of physostigmine carbamate derivatives from (1997-10-14),
8. 5614631 - 1-alkyl-,1-alkenyl-, and 1-alkynylaryl-2-amino-1,3-propanediols and (1997-03-25),
9. 5597838 - 1-alkyl-, 1-alkenyl-, and 1-alkynylaryl-2-amino-1,3-propanediols and (1997-01-28),
10. 5574164 - 1-alkyl-,1-alkenyl-, and 1-alkynylaryl-2-amino-1,3-propanediols and (1996-11-12),
11. 5571923 - 1-Alkyl-, 1-alkenyl-, and 1-alkynylaryl-2-amino-1,3-propanediols and (1996-11-05),
12. 5565584 - 1-alkyl-, 1-alkenyl-, and 1-alkylnlaryl-2-amino-1,3-propanediols and (1996-10-15),
13. 5557006 - 1-Alkyl-, 1-alkenyl-, and 1-alkynylaryl-2-amino-1,3-propanediols and (1996-09-17),
14. 5550247 - 1-alkyl-, 1-alkenyl-, and 1-alkynlaryl-2-amino-1, 3-propanediols and (1996-08-27),
15. 5534640 - 1-alkyl-, 1-alkenyl-, and 1-alkynylaryl-2-amino-1,3-propanediols and (1996-07-09),

Title: Barbara S Rauckman: A Pioneer in Pharmaceutical Innovation

Introduction

Barbara S Rauckman, a distinguished inventor residing in Flemington, NJ, has made significant contributions to the field of pharmaceuticals with 20 patents to her name. Her innovative work primarily focuses on compounds that address critical health issues, particularly in the area of respiratory and neurological disorders.

Latest Patents

Among her notable inventions is the patent for Pyrimidine hydrazide compounds as PGDS inhibitors. This invention is dedicated to a specific compound of formula (I), designed to treat allergic and inflammatory disorders such as allergic rhinitis, asthma, and chronic obstructive pulmonary disease (COPD). Another groundbreaking patent involves thienoisoxazolyl- and thienylpyrrazolyl-phenoxy substituted propyl derivatives. These compounds serve as D antagonists, beneficial for treating a variety of medical conditions, including Attention Deficit Hyperactivity Disorder, Obsessive-Compulsive Disorder, Psychoses, Substance Abuse, and Parkinson's Disease. Furthermore, this patent details pharmaceutical compositions, intermediates, and methods for synthesizing these innovative compounds.

Career Highlights

Barbara's career highlights include her pivotal roles at Hoechst Roussel Pharmaceuticals and Hoechst Marion Roussel, where she honed her expertise in pharmaceutical development and innovation. Her relentless pursuit of advancements in medicine showcases her commitment to improving patient care through innovative therapies.

Collaborations

Throughout her career, Barbara has collaborated with other esteemed professionals in her field, including Gregory H Merriman and Brian S Freed. Their combined efforts have contributed to the successful development and patenting of several influential pharmaceutical compounds.

Conclusion

Barbara S Rauckman's impressive portfolio of patents and her collaborative spirit underline her status as a key figure in pharmaceutical innovation. Her dedication to addressing complex medical challenges continues to have a profound impact on the industry and patients worldwide. With her contributions, Barbara paves the way for future advancements in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…